| 10 mg/ml Solution for infusion EU/1/19/1383/001-002 |
Lacosamide |
UCB Pharma S.A. |
— |
| 100 units/mL Tempo Pen solution for injection in pre-filled pen EU/1/20/1422/016-017 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| 200 units/mL KwikPen solution for injection in pre-filled pen EU/1/20/1422/013-015 |
Insulin lispro |
Eli Lilly Nederland B.V. |
— |
| ABASAGLAR 100 units/mL solution for injection in a cartridge EU/1/14/944/001-004 |
Insulin glargine |
Eli Lilly Nederland B.V. |
— |
| ABASAGLAR 100 units/mL solution for injection in a pre-filled pen EU/1/14/944/005-008 |
Insulin glargine |
Eli Lilly Nederland B.V. |
— |
| Abecma 260 - 500 x 106 cells dispersion for infusion EU/1/21/1539/001 |
Idecabtagene Vicleucel |
Bristol-Myers Squibb Pharmaceuticals uc |
— |
| Abevmy 25 mg/mL concentrate for solution for infusion EU/1/20/1515/001-005 |
Bevacizumab |
Biosimilar Collaborations Ireland Limited |
— |
| Abilify 1 mg/mL oral solution EU/1/04/276/033-035 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 10 mg orodispersible tablets EU/1/04/276/024-026 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 10 mg tablets EU/1/04/276/006-010 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 15 mg orodispersible tablets EU/1/04/276/027-029 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 15 mg tablets EU/1/04/276/011-015 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 30 mg orodispersible tablets EU/1/04/276/030-032 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 30 mg tablets EU/1/04/276/016-020 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 5 mg tablets EU/1/04/276/001-005 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify 7.5 mg/mL solution for injection EU/1/04/276/036 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify Maintena 300 mg powder and solvent for prolonged-release suspension for injection EU/1/13/882/001,003 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify Maintena 400 mg powder and solvent for prolonged-release suspension for injection EU/1/13/882/002,004 |
Aripiprazole |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify Maintena 720 mg prolonged-release suspension for injection in pre-filled syringe EU/1/13/882/009 |
Aripiprazole Monohydrate |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abilify Maintena 960 mg prolonged-release suspension for injection in pre-filled syringe EU/1/13/882/010 |
Aripiprazole Monohydrate |
Otsuka Pharmaceutical Netherlands B.V. |
— |
| Abiraterone Accord 250 mg tablets EU/1/20/1512/001 |
Abiraterone acetate |
Accord Healthcare S.L.U. |
— |
| Abiraterone Accord 500 mg film-coated tablets EU/1/20/1512/002-003 |
Abiraterone acetate |
Accord Healthcare S.L.U. |
— |
| Abiraterone Krka 500 mg film-coated tablets EU/1/21/1553/001-003 |
Abiraterone acetate |
KRKA, d.d., Novo mesto |
— |
| Abiraterone Mylan 1000 mg film-coated tablets EU/1/21/1571/009-012 |
Abiraterone acetate |
Mylan Pharmaceuticals Limited |
— |
| Abiraterone Mylan 500 mg film-coated tablets EU/1/21/1571/001-008 |
Abiraterone acetate |
Mylan Pharmaceuticals Limited |
— |
| Abiraterone Rowa 500 mg Film-coated tablets PA0074/092/001 |
Abiraterone acetate |
Rowa Pharmaceuticals Limited, |
Marketed |
| Abraxane 5 mg/ml powder for dispersion for infusion EU/1/07/428/001 |
Paclitaxel |
Bristol-Myers Squibb Pharma EEIG |
— |
| Abrysvo powder and solvent for solution for injection Respiratory syncytial virus vaccine (bivalent, recombinant) EU/1/23/1752/001-006 |
Respiratory syncytial virus, subgroup A, stabilized prefusion F protein 847A, Respiratory syncytial virus, subgroup B, stabilized prefusion F protein 847B |
Pfizer Europe MA EEIG |
— |
| Abseamed 1 000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/412/1-2 |
Recombinant human erythropoietin alfa |
Medice Arzneimittel Putter GmbH & Co. K.G |
— |
| Abseamed 10 000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/412/15-16 |
Recombinant human erythropoietin alfa |
Medice Arzneimittel Putter GmbH & Co. K.G |
— |
| Abseamed 2 000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/412/3-4 |
Recombinant human erythropoietin alfa |
Medice Arzneimittel Putter GmbH & Co. K.G |
— |
| Abseamed 20 000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/412/021-22 |
Epoetin alfa |
Medice Arzneimittel Putter GmbH & Co. K.G |
— |
| Abseamed 3 000 IU/0.3 mL solution for injection in a pre-filled syringe EU/1/07/412/5-6 |
Recombinant human erythropoietin alfa |
Medice Arzneimittel Putter GmbH & Co. K.G |
— |
| Abseamed 30 000 IU/0.75 mL solution for injection in a pre-filled syringe EU/1/07/412/023-24 |
Epoetin alfa |
Medice Arzneimittel Putter GmbH & Co. K.G |
— |
| Abseamed 4 000 IU/0.4 mL solution for injection in a pre-filled syringe EU/1/07/412/7-8 |
Recombinant human erythropoietin alfa |
Medice Arzneimittel Putter GmbH & Co. K.G |
— |
| Abseamed 40 000 IU/1 mL solution for injection in a pre-filled syringe EU/1/07/412/025-26 |
Epoetin alfa |
Medice Arzneimittel Putter GmbH & Co. K.G |
— |
| Abseamed 5 000 IU/0.5 mL solution for injection in a pre-filled syringe EU/1/07/412/9-10 |
Recombinant human erythropoietin alfa |
Medice Arzneimittel Putter GmbH & Co. K.G |
— |
| Abseamed 6 000 IU/0.6 mL solution for injection in a pre-filled syringe EU/1/07/412/11-12 |
Recombinant human erythropoietin alfa |
Medice Arzneimittel Putter GmbH & Co. K.G |
— |
| Abseamed 8 000 IU/0.8 mL solution for injection in a pre-filled syringe EU/1/07/412/13-14 |
Recombinant human erythropoietin alfa |
Medice Arzneimittel Putter GmbH & Co. K.G |
— |
| Accofil 30 MU/0.5 ml solution for injection/infusion in pre-filled syringe EU/1/14/946/001-002 |
Filgrastim |
Accord Healthcare S.L.U. |
— |
| Accofil 48 MU/0.5 ml solution for injection/infusion in pre-filled syringe EU/1/14/943/003-004 |
Filgrastim |
Accord Healthcare S.L.U. |
— |
| Aclasta 5 mg solution for infusion EU/1/05/308/001 |
Zoledronic acid |
Sandoz Pharmaceuticals d.d. |
— |
| Actelsar HCT 40 mg/12.5 mg tablets EU/1/13/817/001-013 |
Hydrochlorothiazide, Telmisartan |
Actavis Group hf |
— |
| Actelsar HCT 80 mg/12.5 mg tablets EU/1/13/817/014-028 |
Hydrochlorothiazide, Telmisartan |
Actavis Group hf |
— |
| Actelsar HCT 80 mg/25 mg tablets EU/1/13/817/029-041 |
Hydrochlorothiazide, Telmisartan |
Actavis Group hf |
— |
| ACTIFED 30 mg/1.25 mg per 5 ml Syrup PA23490/029/001 |
PSEUDOEPHEDRINE HYDROCHLORIDE, TRIPROLIDINE HYDROCHLORIDE |
JNTL Consumer Health I (Ireland) Limited |
Not marketed |
| Actifed 60mg/2.5mg Tablets PA23490/029/002 |
PSEUDOEPHEDRINE HYDROCHLORIDE, TRIPROLIDINE HYDROCHLORIDE |
JNTL Consumer Health I (Ireland) Limited |
Marketed |
| Actos EU/1/00/150/002 |
Pioglitazone |
CHEPLAPHARM Arzneimittel GmbH |
— |
| Actos EU/1/00/150/005 |
Pioglitazone |
CHEPLAPHARM Arzneimittel GmbH |
— |
| Actos EU/1/00/150/011 |
Pioglitazone |
Takeda Pharma A/S |
— |